Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Risk and Severity of Infusion-Related Reactions in Patients Premedicated With Cetirizine Versus Diphenhydramine Prior to Ocrelizumab Infusions

NCT04175834 is registered in ClinicalTrials.gov with Providence Health & Services as lead sponsor.

NCT NCT04175834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04175834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Risk and Severity of Infusion-Related Reactions in Patients Premedicated With Cetirizine Versus Diphenhydramine Prior to Ocrelizumab Infusions
Lead sponsor
Providence Health & Services
Phase
Phase 3
Overall status
Completed
Start date
February 5, 2020
Completion date
May 13, 2022
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infusion reaction, multiple sclerosis